Neucodia is a novel electrophysiological instrument
designed for quick and reliable visual function assessment in clinical
environment. Collaborated with leading clinicians and scientists across US, the clinical testing and evaluation included early stage glaucoma, diabetic reinopathy and amblyopia. Check the applications you are interested
for clinical testing cases. The following is a list of some advantages of using Neucodia:
Unlike conventional VEP
test, novel visual stimulation including patented icVEP pattern can tap the specific visual neural pathways. Automated data collection, display and artifact rejection and the feature that
enables a simple final result “Pass” or “Fail” based on statistical algorithms simplifies interpretation.
No verbal response or “button pushing” is required, which enables testing of preverbal children, infants, and patients with communication
disabilities. Automated visual acuity estimation in Snellen chart system is also available.
Designed for use in a physician’s office. Neucodia is operator and patient friendly. All the tests are non-invasive. Each test can be completed in a few minutes, and results are